Epameinondas Dogeas, MD
Dr. Epameinondas Dogeas is a surgical oncologist at Banner MD Anderson Cancer Center in Phoenix, Arizona. His clinical practice focuses on the surgical management of complex gastrointestinal and hepato-pancreatobiliary cancers. He performs robotic-assisted complex abdominal operations, including cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients diagnosed with malignant peritoneal mesothelioma.[1]
Dr. Dogeas’ care philosophy centers on empathizing with his patients’ fears and providing them with the information they need about their disease and treatment options so that they can make the most informed decisions possible.
Education and Career
Dr. Dogeas earned his medical degree at the University of Athens School of Medicine. He completed an internship in General Surgery at the Johns Hopkins University Hospital, followed by a General Surgery residency at the University of Texas Southwestern. After completing his residency, he completed a two-year dual fellowship in Complex General Surgical Oncology and Hepato-pancreatobiliary Surgery at the University of Pittsburgh.[1]
In addition to his role at Banner Health, Dr. Dogeas is also a Clinical Assistant Professor at the University of Arizona College of Medicine in Phoenix.
Professional Memberships and Activities
Dr. Dogeas is actively involved in a variety of professional activities, including serving as a reviewer for the journal Translational Gastroenterology and Hepatology. He is also a committee member on the Society for Surgery of the Alimentary Tract’s Communications Committee.[1]
He is a member of several other professional organizations, including:[2]
- American Society of Clinical Oncology – ASCO
- Society of Surgical Oncology
- American College of Surgeons
- Association for Academic Surgery
- Alpha Omega Alpha Honor Medical Society
Research
Dr. Dogeas’s research interests encompass clinical outcomes of primary and metastatic hepatic neoplasms, investigating the diverse biology of neuroendocrine tumors, and understanding the mechanisms of chemotherapy resistance in colorectal cancer.[1]
His recent publications include:[2]
Long-term overall survival in patients undergoing liver resection for metastatic anal squamous cell carcinoma. Winifred M Lo, Epameinondas Dogeas, Mark S Etherington, Cristina Ferrone, Martina Nebbia, Sean Cleary, Ron Pery, Jennifer L Steel, Samer T Tohme, David A Geller>; Journal of Surgical Oncology. 2024 Mar 1
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome. Giammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, Francesca Ratti, Carlo Sposito, Martina Nebbia, Daniel M D’Souza, Franco Pascual, Samer Tohme, Francesco Enrico D…>; Annals of Surgery. 2023 Nov 1
Response to: Comment on: Textbook Outcomes following Open Live Donor Right Hepatectomy and Open Right Hepatic Lobectomy for Cancer in 686 patients: Re-defining the Ben… Epameinondas Dogeas, David A Geller, Abhinav Humar>; Annals of Surgery Open. 2023 Mar 1
